Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020

SELL
$18.24 - $21.45 $227,252 - $267,245
-12,459 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$16.28 - $25.63 $1.12 Million - $1.77 Million
-69,013 Reduced 84.71%
12,459 $251,000
Q4 2019

Feb 13, 2020

SELL
$19.57 - $23.52 $657,552 - $790,272
-33,600 Reduced 29.2%
81,472 $1.9 Million
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $2.28 Million - $2.62 Million
115,072 New
115,072 $2.31 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.